Sensex

Tuesday, January 01, 2008

$$ DreamGains !! $$ Subex Azure - Merrill Lynch Bought 10,00,000 Shares on October 25, 2007

25-Oct-2007

Subex Azure (BSE)

Merrill Lynch Capital Markets Espana S.a. S.v.

BUY

1000000

330.04

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Ads on Yahoo!

Learn more now.

Reach customers

searching for you.

Special K Challenge

on Yahoo! Groups

Find shape-up

tips and tools.

.

__,_._,___

$$ DreamGains !! $$ Subex Azure - CitiGroup Global Mauritius Bought 4,95,646 Shares on December 06, 2007

06-Dec-2007

Subex Azure (BSE)

Citigroup Global Markets Mauritius Pvt Ltd

BUY

252646

303.00

06-Dec-2007

Subex Azure (NSE)

Citigroup Global Markets Mauritius Private Limited

BUY

243000

303.00

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

New business?

Get new customers.

List your web site

in Yahoo! Search.

Yahoo! Groups

Wellness Spot

A resource for Curves

and weight loss.

.

__,_._,___

$$ DreamGains !! $$ FW: Sharekhan Post-Market Report dated January 01, 2008

 

 

From: The Sharekhan Research Team [mailto:marketwatch@research.sharekhan.com]
Sent: 01 January 2008 18:56
To: The Sharekhan Research Team
Subject: Sharekhan Post-Market Report dated January 01, 2008

 

 

 Sharekhan's daily newsletter

Visit us at www.sharekhan.com

 

January 01, 2008

 

Index Performance

Index

Sensex

Nifty

Open

20,325.27

6,136.75

High

20,394.89

6,165.35

Low

20,220.46

6,109.85

Today's Cls

20,300.71

6,144.35

Prev Cls

20,286.99

6,138.60

Change

13.72

5.75

% Change

0.07

0.09

 

Market Indicators

Top Movers (Group A)

Company

Price 
(Rs)

%
chg

Gainers

JB Chemicals

98.25

19.96

Indo Rama Synthetics

78.50

19.94

Apollo Hospitals

596.30

13.53

EIH

207.50

12.44

Indian Hotels

174.30

9.24

Losers

Ramco Systems

230.90

-6.00

Essel Propack

73.35

-4.93

Cairn India

247.90

-3.80

Aventis Pharma

1,121.50

-3.58

Mphasis

296.65

-3.25

Market Statistics

-

BSE

NSE

Advances

2,282

847

Declines

626

348

Unchanged

26

4

Volume(Nos)

66.32cr

81.66cr

 Market Commentary 

Sensex gains in lacklustre New Year trades

The Sensex traded flat for the better part of the day and gained 14 points on late-round buying in FMCG, power, and realty stocks.

It has been a quiet start for the markets in the New Year.  

 

As most of the Asian markets were closed on account of New Year, the Sensex resumed 38 points above its previous close of 20,325. But, slipped immediately to touch the day's low of 20,220 on the back of selling in information technology, oil and consumer durables stocks. However, selective buying in index pivotal, fast moving consumer goods (FMCG) and power stocks helped the Sensex enter the green once again and touch the day's high of 20,395. Lack of buying interest kept the market in a range thereafter. After hovering around its previous close in the afternoon, the Sensex finally closed the session with a gain of 14 points at 20,301. Broad based Nifty closed at 6,144, up six points. 

Broader markets outperformed the frontliners giving markets positive breadth. Of the 2,934 stocks traded on the Bombay Stock Exchange (BSE), 2,282 stocks advanced, 626 stocks declined and 26 stocks ended unchanged. Among the sectoral indices the BSE Realty index moved up by 2.44% at 13,038 followed by the BSE FMCG index (up 2.38% at 2,375) and the BSE Power index (up 2.17% at 4,648). However, the BSE CD index, the BSE CG index, the BSE HC index, the BSE IT index, the BSE Oil & Gas index and the BSE Teck index fell around 1% each. 

Reliance Energy witnessed strong buying interest and soared 6.76% at Rs2,279, ITC rose 3.47% at Rs218, Grasim Industries was up 3.03% at Rs3,762, Tata Motors shot up by 2.82% at Rs763, NTPC jumped 2.70% at Rs257, HLL added 1.96% at Rs218 and HDFC gained 1.61% at Rs2,919. However, TCS slipped 2.74% at Rs1,054, Bharti Airtel lost 2.71% at Rs968, Wipro dipped 1.90% at Rs516 and Satyam Computer was down 1.24% at Rs444.

Over 2.41 crore GV Films shares changed hands on the BSE followed by IFCI (2.38 crore shares), GTL Infrastructure (1.50 crore shares), Centurion Bank of Punjab (1.50 crore shares) and Hindustan Motors (1.15 crore shares).

Valuewise, Reliance Energy registered a turnover of Rs311 crore on the BSE followed by Essar Oil (Rs247 crore), IFCI (Rs232 crore), Reliance Petroleum (Rs208 crore) and GTL Infrastructure (Rs152 crore).

To know more about our products and services, click here.

“This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. 
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.”

To unsubscribe write to myaccount@sharekhan.com

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Ads on Yahoo!

Learn more now.

Reach customers

searching for you.

Green Groups

on Yahoo! Groups

share your passion

for the planet.

.

__,_._,___

$$ DreamGains !! $$ FW: Tata Chemicals: Sharekhan Stock Idea dated December 31, 2007

 

 

From: The Sharekhan Research Team [mailto:marketwatch@research.sharekhan.com]
Sent: 31 December 2007 17:30
To: The Sharekhan Research Team
Subject: Tata Chemicals: Sharekhan Stock Idea dated December 31, 2007

 

 

Stock Idea
[December 31, 2007] Please see the attachment for details

Sharekhan
www.sharekhan.com

Summary of Contents

STOCK IDEA

Tata Chemicals                
Cluster: Ugly Duckling
Recommendation: Buy
Price target: Rs535
Current market price: Rs411

Riding on uptrend in soda ash cycle

Key points  

  • Soda ash prices up by 60%: Tata Chemicals Ltd (TCL), the third largest producer of soda ash in the world, is set to benefit from the upturn in the soda ash cycle. A worldwide shortage of soda ash has pushed its prices up by 60% to $260-300 per tonne in the last six months. Since the supply of soda ash is expected to remain tight, its prices would stay firm going forward.
  • Soda ash capacity addition to lead to volume growth: TCL has recently added 365,000tpa of capacity at its Kenyan (Magadi) plant, which is the lowest cost producer of soda ash in the world. It is also planning to raise its Magadi capacity by another 365,000tpa to 1.1mmtpa by FY2011. It has also undertaken the debottlenecking of its Mithapur plant to raise the latter's capacity from 0.9mmtpa to 1.2mmtpa by FY2011. 
  • Windfall profits awaiting de-bottlenecking of urea capacity: After the de-bottlenecking of the urea capacity to 1.2mmtpa by September 2008, the normative capacity utilisation would reach 145%. This would generate windfall profits for the company till capacity re-rating takes place in FY2011.
  • IMACID JV to benefit from higher prices of phosphoric acid: Higher phosphoric acid prices due to a shortage coupled with a better pricing policy would further improve the profit margins for the IMACID joint venture.
  • Investment portfolio worth Rs187 per share: TCL's investment portfolio of Rs775 crore (book value) is worth Rs4,600 crore, which works out to Rs187 per share.
  • Valuation: At the current market price of Rs411, the stock is trading at 13.5x its FY2009E diluted earnings and an EV/EBIDTA of 6.6x. We value TCL's core business at 14.4x its FY2009E diluted earnings and investments at Rs94.8 per share after discounting 50% of their fair value. We recommend Buy on the stock with a price target of Rs535.

Regards,
The Sharekhan Research Team

myaccount@sharekhan.com

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

New business?

Get new customers.

List your web site

in Yahoo! Search.

Cat Fanatics

on Yahoo! Groups

Find people who are

crazy about cats.

.

__,_._,___